Gastric MALT lymphoma and Helicobacter pylori

Med Clin (Barc). 2019 Jan 18;152(2):65-71. doi: 10.1016/j.medcli.2018.09.006. Epub 2018 Nov 10.
[Article in English, Spanish]

Abstract

Marginal zone lymphomas of the MALT type are a type of B-cell neoplasms that involve extranodal tissues and have an indolent clinical behaviour. The stomach is the most common site and most patients are infected by Helicobacter pylori. An increase in the resistance of this bacterium to several antibiotics has been observed in the last years and this fact has determined the review of treatment guidelines. In areas with resistance to clarithromycin greater than 15%, classical triple therapy should be abandoned and quadruple regimens with or without bismuth are currently recommended. Thus, these new guidelines for eradication treatment should be applied to patients with gastric MALT lymphoma associated with H. pylori infection.

Keywords: Eradication treatment; Gastric lymphoma; Helicobacter pylori; Linfoma MALT; Linfoma gástrico; MALT lymphoma; Tratamiento erradicador.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / therapeutic use
  • Breath Tests
  • Clarithromycin / therapeutic use
  • Drug Resistance, Multiple, Bacterial
  • Drug Therapy, Combination
  • Gastritis / complications*
  • Gastritis / drug therapy
  • Gastroscopy
  • Helicobacter Infections / complications*
  • Helicobacter Infections / diagnosis
  • Helicobacter Infections / drug therapy
  • Helicobacter Infections / microbiology
  • Helicobacter pylori / drug effects
  • Helicobacter pylori / isolation & purification
  • Helicobacter pylori / pathogenicity*
  • Humans
  • Lymphoma, B-Cell, Marginal Zone / etiology
  • Lymphoma, B-Cell, Marginal Zone / microbiology*
  • Lymphoma, B-Cell, Marginal Zone / therapy
  • Omeprazole / administration & dosage
  • Omeprazole / therapeutic use
  • Organometallic Compounds / administration & dosage
  • Organometallic Compounds / therapeutic use
  • Practice Guidelines as Topic*
  • Proton Pump Inhibitors / administration & dosage
  • Proton Pump Inhibitors / therapeutic use
  • Salvage Therapy
  • Stomach Neoplasms / etiology
  • Stomach Neoplasms / microbiology*
  • Stomach Neoplasms / therapy

Substances

  • Anti-Bacterial Agents
  • Organometallic Compounds
  • Proton Pump Inhibitors
  • Clarithromycin
  • bismuth tripotassium dicitrate
  • Omeprazole